ALIROCUMAB — all Canadian products
5 DINs
3 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ALIROCUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02453819 | PRALUENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | ALIROCUMAB 75 MG | Marketed | |
| 02453835 | PRALUENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | ALIROCUMAB 150 MG | Marketed | |
| 02547732 | PRALUENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | ALIROCUMAB 300 MG | Marketed | |
| 02453754 | PRALUENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | ALIROCUMAB 75 MG | Cancelled Post Market | |
| 02453762 | PRALUENT | SANOFI-AVENTIS CANADA INC | Solution | Subcutaneous | ALIROCUMAB 150 MG | Cancelled Post Market |
Browse other molecules: